Indication

Thrombosis in heparin-induced thrombocytopenia

Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin. Read more about Thrombosis in heparin-induced thrombocytopenia

28 drugs 23 manufacturers

Advertisement

Drugs that treat it

Common Thrombosis in heparin-induced thrombocytopenia therapies.

Showing 19–27 of 28 drugs

ARGATROBAN

THROMBIN INHIBITORS (NON-HEPARINOID)·THROMBOSIS IN HEPARIN-INDUCED THROMBOCYTOPENIA·+2
PAR PHARMACEUTI
Filter & compare in the drug finder →Opens the drug finder with Thrombosis in heparin-induced thrombocytopenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Thrombosis in heparin-induced thrombocytopenia.

Thrombosis in heparin-induced thrombocytopenia, also referred to as heparin-induced thrombocytopenia with thrombosis, is a life-threatening, paradoxical prothrombotic complication occurring in patients exposed to unfractionated or low-molecular-weight heparin.

This disorder arises when IgG autoantibodies form against complexes of platelet factor 4 and heparin, which bind platelet Fc?RIIa receptors to trigger extensive platelet activation, aggregation, and substantial thrombin generation.

Primarily affecting the vascular and hematologic systems, it leads to a typical drop in platelet counts alongside high risks of new or progressive venous and arterial thromboembolic events, such as deep vein thrombosis, pulmonary embolism, stroke, limb ischemia, or acute myocardial infarction.

Personalize your experience

Follow Thrombosis in heparin-induced thrombocytopenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it